[go: up one dir, main page]

Feher et al., 1989 - Google Patents

Liver cell protection in toxic liver lesion.

Feher et al., 1989

Document ID
13409917203148573411
Author
Feher J
Cornides A
Pal J
Lang I
Csomos G
Publication year
Publication venue
Acta Physiologica Hungarica

External Links

Snippet

Most of the hepatoprotective drugs belong to the group of free radical scavangers. The mechanism of their action involves membrane stabilisation, neutralisation of free radicals and immunomodulation. The authors demonstrate the effect of different-drugs used in …
Continue reading at europepmc.org (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]

Similar Documents

Publication Publication Date Title
Roerig et al. First pass uptake of fentanyl, meperidine, and morphine in the human lung.
Iwagami Changes in the ultrastructure of human cells related to certain biological responses under hyperthermic culture conditions.
Láng et al. Hepatoprotective and immunological effects of antioxidant drugs.
Gil et al. Parenteral nutrition and oral intake: effect of branched-chain amino acids.
Feher et al. Liver cell protection in toxic liver lesion.
Johansen Acarbose treatment of sulfonylurea-treated non-insulin dependent diabetics. A double-blind cross-over comparison of an alpha-glucosidase inhibitor with metformin.
Gorban et al. Clinical and experimental study of spirulina efficacy in chronic diffuse liver diseases
Smeesters et al. Efficacy of incorporating cyclosporine into liposomes to reduce its nephrotoxicity.
Pestelli et al. Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients.
Deák et al. Effects of two bioflavonoids on certain cellular immune reactions in vitro.
Matsuo et al. Synergistic cytotoxic effects of tumor necrosis factor, interferon-gamma and tamoxifen on breast cancer cell lines.
Shupak et al. Three-years' experience of transdermal scopolamine: long-term effectiveness and side-effects.
Hagelund et al. Absorption of rifampicin in gastrectomized patients. Effect of meals.
Gifford et al. Tumour necrosis factor.
Rieger Interferon-alpha: a clinical update.
Müzes et al. In vitro effect of 4-amino-5-imidazole-carboxamide-phosphate (AICA-P) on the enzyme activity and expression of superoxide dismutase.
Schoorl et al. Laxative policy for terminal patients ineffective
Pár et al. Isoprinosine therapy in chronic hepatitis C (multicenter placebo-controlled double-blind prospective study)
Cremer et al. Inhibitory capacity of some fractions isolated from a green barley extract upon TNF alpha production by the cells of the THP-1 human monocytes line.
Losty et al. Biliary atresia--lessons from the Dublin experience.
Tasaka et al. The Japanese perspective: effects of terfenadine in bronchial asthma: in vitro and in vivo research.
Gemba et al. Stimulation by trifluoperazine of p-aminohippurate accumulation in rat kidney cortical slices.
Blomgren et al. Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitro.
Kuroda et al. Serum concentration of HCFU and 5-FU after oral administration of HCFU in postoperative digestive cancer patients
Kulbertus Clinical trial of the month. The CIBIS-II study